[Skip to Content]
Bleeding and Transfusion

New Oral Anticoagulants and the Risk of Intracranial Hemorrhage Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation

JAMA Neurology
Published Online: October 28, 2014 Video Interview 2 min 55 sec

Author Saurav Chatterjee, MD, discusses New Oral Anticoagulants and the Risk of Intracranial Hemorrhage: Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Oral Anticoagulants and Intracranial Hemorrhage

See More About

Atrial Fibrillation Cardiology Cerebrovascular Disease Clinical Pharmacy and Pharmacology Neurology Stroke Cerebrovascular Hemorrhage Bleeding and Transfusion Rhythm Disorders Anticoagulation
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue